Table 3.
Adjusted relationship between BVS and HADS
| Coefficient | 95% CI | Significance | |
|---|---|---|---|
| Factor of interest | |||
| BVS score (10 units) | −0.15 | [−0.57, 0.27] | 0.49 |
| Adjustment covariates | |||
| Time (weeks) | 0.02 | [−0.10, 0.15] | 0.71 |
| Gender (male) | 0.89 | [−1.08, 2.85] | 0.38 |
| Age (years) | −0.05 | [−0.11, 0.01] | 0.13 |
| Duration of illness (log (days)) | −0.57 | [−1.34, 0.20] | 0.14 |
| MOS Social Support Survey | −0.85 | [−1.89, 0.19] | 0.11 |
| Steroid use | −0.92 | [−3.23, 1.38] | 0.43 |
| Psychotropic use | 0.93 | [−1.23, 3.09] | 0.40 |
| Analgesic use | 0.41 | [−1.49, 2.32] | 0.67 |
| Karnofsky Performance Status score | −0.11 | [−0.18, −0.05] | 0.001 |
From generalised estimating equation model with HADS as dependent variable, on imputed data (n = 170 × 3). BVS, Beliefs and Values Scale; HADS, Hospital Anxiety and Depression Scale; MOS, Medical Outcomes Study.